CYCLIVERT cyclizine hydrochloride tablet

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Ingrédients actifs:

CYCLIZINE HYDROCHLORIDE (UNII: W0O1NHP4WE) (CHLORIDE ION - UNII:Q32ZN48698)

Disponible depuis:

Laser Pharmaceuticals, LLC

DCI (Dénomination commune internationale):

CYCLIZINE HYDROCHLORIDE

Composition:

CYCLIZINE HYDROCHLORIDE 25 mg in 25 mg

Type d'ordonnance:

OTC DRUG

Statut de autorisation:

OTC monograph final

Résumé des caractéristiques du produit

CYCLIVERT - CYCLIZINE HYDROCHLORIDE TABLET
LASER PHARMACEUTICALS, LLC
_Disclaimer: Most OTC drugs are not reviewed and approved by FDA,
however they may be marketed if they_
_comply with applicable regulations and policies. FDA has not
evaluated whether this product complies._
----------
ACTIVE INGREDIENT SECTION
Active Ingredient (in each tablet) Cyclizine Hydrochloride 25 mg
PURPOSE SECTION
Purpose Antiemetic
KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
INDICATIONS AND USES SECTION
Uses For the prevention and treatment of the nausea, vomiting, or
dizziness associated with motion
sickness. For the treatment of vertigo of motion sickness.
WARNINGS SECTION
Warnings
Do not exceed recommended dosage.
Ask a doctor or pharmacist before use if you have a breathing problem
such as emphysema or chronic
bronchitis glaucoma difficulty in urination due to enlargement of the
prostate gland
Ask a doctor before use if you are taking sedatives, or tranquilizers.
Do not give this product to children who have a breathing problem such
as chronic bronchitis or who
have glaucoma, without first consulting the child's doctor.
Do not give to children under 6 years of age unless directed by a
doctor.
When using this product you may get drowsy avoid alcohol drinks
alcohol, sedatives, and tranquilizers
may increase the drowsiness effect be careful when driving a motor
vehicle or operating machinery
In case of overdose, get medical help or contact a Poison Control
Center right away.
PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
DOSAGE AND ADMINISTRATION
Directions
Adults and children 12 years of age and over: 2 tablets every 4-6
hours, not to exceed 8 tablets in 24
hours.
Children 6 to under 12 years of age: 1 tablet every 6-8 hours, not to
exceed 3 tablets in 24 hours.
Children under 6 years of age: Consult a physician.
INACTIVE INGREDIENTS SECTION
Inactive ingredients magnesium Stearate, Microcrystalline Cellouse,
Sodium Starch Glycolate
OTHER INFORMATION